Covance Periapproval Services Inc.

Covance Reports Third Quarter Revenue of $475M and EPS of $0.67 Per Share.
PR Newswire; 10/21/2009; 3963 words; ...FirstCall/ -- Covance Inc. today reported...represented 59% of Covance's third quarter...clinical pharmacology services, and research...Early Development service offerings led...commercialization services (periapproval and market access...

www.PicksThatMove.com: "Picks that move" Alerts, September 18, 2009: MAN, CVD, STWD. GGG, BGF and TE.
M2 Presswire; 9/21/2009; 2357 words; ...presentation at www.covance.com. In order...10 minutes early. Covance Inc. is a drug development services company providing...food industries. Covance maintains offices...clinical development, periapproval and market access...

BUSINESS AND PEOPLE UPDATE
Applied Clinical Trials; 9/1/2009; 1876 words; ...recognized for her services to the pharmaceutical...PA) eClinical Service Division, Jonathan...will oversee Covance's (Princeton...biostatistics for periapproval services. * Previously...operations within the services branch of CRF...Neuropsychiatry to INC Research's...to ...

Covance Reports Second Quarter Revenue of $466M and EPS of $0.66.
PR Newswire; 7/29/2009; 4032 words; ...FirstCall/ -- Covance Inc. today reported...centralized ECG and IVRS service lines and using June...clinical pharmacology services, and research products...commercialization services (periapproval services and market access...

Covance Announces Monte Jarvis as Vice President of Global Data Management and Biostatistics for Periapproval Services.(Clinical report)
Biotech Week; 6/17/2009; 917 words; Covance Inc. announced Monte Jarvis...and biostatistics for periapproval services. With more than 25...and general manager, periapproval services, Covance. "His extensive experience...Administration, Covance Inc. This article was prepared...